Christopher Salerno to Retrospective Studies
This is a "connection" page, showing publications Christopher Salerno has written about Retrospective Studies.
Connection Strength
0.784
-
Elective HeartWare HVAD to HeartMate 3 Pump Exchange: Risk Mitigation or Increasing Risk? Ann Thorac Surg. 2023 08; 116(2):438-440.
Score: 0.074
-
HVAD to HeartMate 3 left ventricular assist device exchange: Best practices recommendations. Eur J Cardiothorac Surg. 2022 06 15; 62(1).
Score: 0.072
-
HVAD to HeartMate 3 left ventricular assist device exchange: Best practices recommendations. J Thorac Cardiovasc Surg. 2022 06; 163(6):2120-2127.e5.
Score: 0.070
-
HVAD to HeartMate 3 Left Ventricular Assist Device Exchange: Best Practices Recommendations. Ann Thorac Surg. 2022 06; 113(6):1770-1777.
Score: 0.070
-
INTERMACS profiles and modifiers: Heterogeneity of patient classification and the impact of modifiers on predicting patient outcome. J Heart Lung Transplant. 2016 Apr; 35(4):440-8.
Score: 0.045
-
Early elevations in pump power with the HeartMate II left ventricular assist device do not predict late adverse events. J Heart Lung Transplant. 2014 Aug; 33(8):809-15.
Score: 0.040
-
Open-chest management after heart transplantation. Tex Heart Inst J. 2006; 33(3):306-9.
Score: 0.023
-
Cost effectiveness of commercial portable ex vivo lung perfusion at a low-volume US lung transplant center. Artif Organs. 2024 Nov; 48(11):1288-1296.
Score: 0.021
-
Increasing Utilization of Extended Criteria Donor Hearts for Transplantation: The OCS Heart EXPAND Trial. JACC Heart Fail. 2024 Mar; 12(3):438-447.
Score: 0.020
-
Impact of prophylactic donor heart tricuspid valve annuloplasty on outcomes in heart transplantation. J Cardiothorac Surg. 2023 Oct 12; 18(1):288.
Score: 0.020
-
Status One and Status Two Exception Use in the Updated Heart Allocation System. J Card Fail. 2023 06; 29(6):963-967.
Score: 0.019
-
The prognostic role of advanced hemodynamic variables in patients with left ventricular assist devices. Artif Organs. 2023 Mar; 47(3):574-581.
Score: 0.018
-
Decreasing blood wastage during ex vivo lung perfusion recovery through utilization of thermal control technology. J Card Surg. 2022 Dec; 37(12):5011-5018.
Score: 0.018
-
Clinical outcomes of grafted vs. percutaneous axillary intra-aortic balloon pump support as a bridge to transplantation: a propensity score-matched analysis. Heart Vessels. 2022 Dec; 37(12):1995-2001.
Score: 0.018
-
Concurrent valvular procedures during left ventricular assist device implantation and outcomes: A comprehensive analysis of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 trial portfolio. J Thorac Cardiovasc Surg. 2023 12; 166(6):1684-1694.e18.
Score: 0.018
-
Comparing short-term/long-term outcomes of heart transplants that occur inside and outside of normal working hours. ESC Heart Fail. 2022 08; 9(4):2484-2490.
Score: 0.018
-
Global best practices consensus: Long-term management of patients with hybrid centrifugal flow left ventricular assist device support. J Thorac Cardiovasc Surg. 2022 10; 164(4):1120-1137.e2.
Score: 0.018
-
Outcomes in Smaller Body Size Adults After HeartMate 3 Left Ventricular Assist Device Implantation. Ann Thorac Surg. 2022 12; 114(6):2262-2269.
Score: 0.018
-
Characteristics and outcomes of patients with COVID-19 supported by extracorporeal membrane oxygenation: A retrospective multicenter study. J Thorac Cardiovasc Surg. 2022 06; 163(6):2107-2116.e6.
Score: 0.017
-
The use of enoxaparin as bridge to therapeutic INR after LVAD implantation. J Cardiothorac Surg. 2020 Nov 14; 15(1):329.
Score: 0.016
-
Impact of left ventricular assist device implantation on mitral regurgitation: An analysis from the MOMENTUM 3 trial. J Heart Lung Transplant. 2020 06; 39(6):529-537.
Score: 0.015
-
Hepatitis C donor viremic cardiac transplantation: A practical approach. Clin Transplant. 2020 01; 34(1):e13764.
Score: 0.015
-
Left Lateral Thoracotomy for Centrifugal Continuous-Flow Left Ventricular Assist Device Placement: An Analysis from the Mechanical Circulatory Support Research Network. ASAIO J. 2018 Nov/Dec; 64(6):715-720.
Score: 0.014
-
Impact of Patient Distance From Ventricular Assist Device-Implanting Center on Short- and Long-Term Outcomes. ASAIO J. 2018 Nov/Dec; 64(6):721-726.
Score: 0.014
-
Bleeding Complication Rates Are Higher in Females after Continuous-Flow Left Ventricular Assist Device Implantation. ASAIO J. 2018 Nov/Dec; 64(6):748-753.
Score: 0.014
-
Surgical therapy for pulmonary aspergillosis in immunocompromised patients. Ann Thorac Surg. 1998 May; 65(5):1415-9.
Score: 0.013
-
Temporal Differences in Outcomes During Long-Term Mechanical Circulatory Support. J Card Fail. 2017 Dec; 23(12):852-858.
Score: 0.013
-
Ventricular Assist Device Therapy in Older Patients With Heart Failure: Characteristics and Outcomes. J Card Fail. 2016 Dec; 22(12):981-987.
Score: 0.012
-
Outcomes of Patients Receiving Temporary Circulatory Support Before Durable Ventricular Assist Device. Ann Thorac Surg. 2017 Jan; 103(1):106-112.
Score: 0.012
-
The HeartMate II Risk Score: An Adjusted Score for Evaluation of All Continuous-Flow Left Ventricular Assist Devices. ASAIO J. 2016 May-Jun; 62(3):281-5.
Score: 0.012
-
Impact of concurrent surgical valve procedures in patients receiving continuous-flow devices. J Thorac Cardiovasc Surg. 2014 Feb; 147(2):581-9; discussion 589.
Score: 0.010
-
Characteristics of extracoronary vascular disease in heart transplant recipient. J Card Surg. 2008 Sep-Oct; 23(5):459-63.
Score: 0.007